Translumina Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Translumina Therapeutics is a global leader in interventional cardiovascular devices. Founded in 2000 in Germany and incorporated in India in 2010, the company excels at developing, manufacturing, and distributing high-quality products such as drug-eluting stents and angioplasty solutions for coronary and vascular care. Translumina operates manufacturing facilities in Germany, the Netherlands, and India, reaching more than 60 countries and maintaining rigorous ISO-certified production standards.

With a headquarters in Delhi, India, Translumina focuses strongly on innovation and quality, offering interventional cardiology and vascular intervention devices—including drug-eluting stents, drug-eluting balloons, and precision vascular accessories. These products support minimally invasive treatment for coronary and peripheral artery disease. The organization collaborates with hospitals, engineering institutes, and internationally recognized cardiologists to improve patient outcomes and the accessibility of advanced cardiovascular care.